Cargando…

Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery

Oral route maintains its predominance among the ones used for drug delivery, especially when medicines are self-administered. If the dosage form is solid, therapy gains in dose precision and drug stability. Yet, some active pharmaceutical substances do not present the required solubility, permeabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Feitosa, Renata Carvalho, Geraldes, Danilo Costa, Beraldo-de-Araújo, Viviane Lucia, Costa, Juliana Souza Ribeiro, Oliveira-Nascimento, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771228/
https://www.ncbi.nlm.nih.gov/pubmed/31607914
http://dx.doi.org/10.3389/fphar.2019.01057
_version_ 1783455653841338368
author Feitosa, Renata Carvalho
Geraldes, Danilo Costa
Beraldo-de-Araújo, Viviane Lucia
Costa, Juliana Souza Ribeiro
Oliveira-Nascimento, Laura
author_facet Feitosa, Renata Carvalho
Geraldes, Danilo Costa
Beraldo-de-Araújo, Viviane Lucia
Costa, Juliana Souza Ribeiro
Oliveira-Nascimento, Laura
author_sort Feitosa, Renata Carvalho
collection PubMed
description Oral route maintains its predominance among the ones used for drug delivery, especially when medicines are self-administered. If the dosage form is solid, therapy gains in dose precision and drug stability. Yet, some active pharmaceutical substances do not present the required solubility, permeability, or release profile for incorporation into traditional matrices. The combination of nanostructured drugs (nanoparticle [NP]) with these matrices is a new and little-explored alternative, which could bring several benefits. Therefore, this review focused on combined delivery systems based on nanostructures to administer drugs by the oral cavity, intended for buccal, sublingual, gastric, or intestinal absorption. We analyzed published NP-in-matrix systems and compared main formulation characteristics, pharmacokinetics, release profiles, and physicochemical stability improvements. The reported formulations are mainly semisolid or solid polymers, with polymeric or lipid NPs and one active pharmaceutical ingredient. Regarding drug specifics, most of them are poorly permeable or greatly metabolized. The few studies with pharmacokinetics showed increased drug bioavailability and, sometimes, a controlled release rate. From our knowledge, the gathered data make up the first focused review of these trendy systems, which we believe will help to gain scientific deepness and future advancements in the field.
format Online
Article
Text
id pubmed-6771228
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67712282019-10-11 Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery Feitosa, Renata Carvalho Geraldes, Danilo Costa Beraldo-de-Araújo, Viviane Lucia Costa, Juliana Souza Ribeiro Oliveira-Nascimento, Laura Front Pharmacol Pharmacology Oral route maintains its predominance among the ones used for drug delivery, especially when medicines are self-administered. If the dosage form is solid, therapy gains in dose precision and drug stability. Yet, some active pharmaceutical substances do not present the required solubility, permeability, or release profile for incorporation into traditional matrices. The combination of nanostructured drugs (nanoparticle [NP]) with these matrices is a new and little-explored alternative, which could bring several benefits. Therefore, this review focused on combined delivery systems based on nanostructures to administer drugs by the oral cavity, intended for buccal, sublingual, gastric, or intestinal absorption. We analyzed published NP-in-matrix systems and compared main formulation characteristics, pharmacokinetics, release profiles, and physicochemical stability improvements. The reported formulations are mainly semisolid or solid polymers, with polymeric or lipid NPs and one active pharmaceutical ingredient. Regarding drug specifics, most of them are poorly permeable or greatly metabolized. The few studies with pharmacokinetics showed increased drug bioavailability and, sometimes, a controlled release rate. From our knowledge, the gathered data make up the first focused review of these trendy systems, which we believe will help to gain scientific deepness and future advancements in the field. Frontiers Media S.A. 2019-09-24 /pmc/articles/PMC6771228/ /pubmed/31607914 http://dx.doi.org/10.3389/fphar.2019.01057 Text en Copyright © 2019 Feitosa, Geraldes, Beraldo-de-Araújo, Costa and Oliveira-Nascimento http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Feitosa, Renata Carvalho
Geraldes, Danilo Costa
Beraldo-de-Araújo, Viviane Lucia
Costa, Juliana Souza Ribeiro
Oliveira-Nascimento, Laura
Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
title Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
title_full Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
title_fullStr Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
title_full_unstemmed Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
title_short Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
title_sort pharmacokinetic aspects of nanoparticle-in-matrix drug delivery systems for oral/buccal delivery
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771228/
https://www.ncbi.nlm.nih.gov/pubmed/31607914
http://dx.doi.org/10.3389/fphar.2019.01057
work_keys_str_mv AT feitosarenatacarvalho pharmacokineticaspectsofnanoparticleinmatrixdrugdeliverysystemsfororalbuccaldelivery
AT geraldesdanilocosta pharmacokineticaspectsofnanoparticleinmatrixdrugdeliverysystemsfororalbuccaldelivery
AT beraldodearaujovivianelucia pharmacokineticaspectsofnanoparticleinmatrixdrugdeliverysystemsfororalbuccaldelivery
AT costajulianasouzaribeiro pharmacokineticaspectsofnanoparticleinmatrixdrugdeliverysystemsfororalbuccaldelivery
AT oliveiranascimentolaura pharmacokineticaspectsofnanoparticleinmatrixdrugdeliverysystemsfororalbuccaldelivery